{"id":59472,"date":"2024-06-03T10:05:05","date_gmt":"2024-06-03T08:05:05","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/"},"modified":"2024-06-03T10:05:05","modified_gmt":"2024-06-03T08:05:05","slug":"mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/","title":{"rendered":"Mursla Bio Presents Breakthrough Liquid Biopsy Technology for Extracellular Vesicles in Cell Press"},"content":{"rendered":"
\n

\nNovel and scalable analysis of extracellular vesicles sub-types detailed in Cell Press\u2019 iScience<\/i><\/b><\/p>\n

CAMBRIDGE, England–(BUSINESS WIRE)–#Cambridge<\/a>—Mursla Bio<\/a> is pleased to announce the publication of its latest peer-reviewed paper in iScience<\/i>, an interdisciplinary journal of the esteemed Cell Press. The paper showcases Mursla Bio\u2019s breakthrough technology for the analysis of extracellular vesicles (EV) sub-types within biofluids such as blood. EVs are important actors in intercellular communication and are set to transform the field of disease diagnostics.<\/p>\n

<\/a>
<\/a><\/p>\n

\nEntitled “An electro-optical platform for the ultrasensitive detection of small extracellular vesicle sub-types and their protein epitope counts<\/a>“, the paper introduces Nano-Extracellular Omics Sensing (NEXOS), a novel and scalable technology which addresses and overcomes previous limitations in the sensitive detection of EV proteins and their quantification.<\/p>\n

\nThe unique features of NEXOS enable the exploration of new biological insights in liquid biopsies and are expected to significantly facilitate the adoption of EVs in clinical settings.<\/p>\n

\nMursla Bio anticipates the publication of additional peer-reviewed papers supporting its clinical study on liver cancer, which is expected to complete later this year.<\/p>\n

\nAbout Mursla Bio<\/b><\/p>\n

\nMursla Bio is a liquid biopsy company decoding extracellular vesicles to enable curative treatments for cancer. Its first-in-class blood test is based on a novel modality, capable of performing a non-invasive liver biopsy at any time. This involves the AI-empowered analysis of the multi-omics content of liver-derived extracellular vesicles from blood. Its flagship test aims to replace ultrasound in the surveillance of liver cancer among 10 million high-risk patients in Western countries.<\/p>\n

\nMursla Bio was selected as UK Life Sciences Innovator 2023<\/a> in the Diagnostics and Precision Medicine category.<\/p>\n

\nDiscover more: mursla.com<\/a><\/p>\n

Contacts<\/b> <\/p>\n

\nMursla Bio, Cambridge, U.K.<\/b>
Tel: +44 (0) 1223 928 141
\n
Email: contact@mursla.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Novel and scalable analysis of extracellular vesicles sub-types detailed in Cell Press\u2019 iScience CAMBRIDGE, England–(BUSINESS WIRE)–#Cambridge—Mursla Bio is pleased to announce the publication of its latest peer-reviewed paper in iScience, an interdisciplinary journal of the esteemed Cell Press. The paper showcases Mursla Bio\u2019s breakthrough technology for the analysis of extracellular vesicles (EV) sub-types within biofluids … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59472","6":"format-standard","7":"category-industry"},"yoast_head":"\nMursla Bio Presents Breakthrough Liquid Biopsy Technology for Extracellular Vesicles in Cell Press - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mursla Bio Presents Breakthrough Liquid Biopsy Technology for Extracellular Vesicles in Cell Press - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Novel and scalable analysis of extracellular vesicles sub-types detailed in Cell Press\u2019 iScience CAMBRIDGE, England–(BUSINESS WIRE)–#Cambridge—Mursla Bio is pleased to announce the publication of its latest peer-reviewed paper in iScience, an interdisciplinary journal of the esteemed Cell Press. The paper showcases Mursla Bio\u2019s breakthrough technology for the analysis of extracellular vesicles (EV) sub-types within biofluids ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-03T08:05:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240603591356\/en\/2146370\/22\/Mursla_Bio_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Mursla Bio Presents Breakthrough Liquid Biopsy Technology for Extracellular Vesicles in Cell Press\",\"datePublished\":\"2024-06-03T08:05:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\\\/\"},\"wordCount\":295,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240603591356\\\/en\\\/2146370\\\/22\\\/Mursla_Bio_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\\\/\",\"name\":\"Mursla Bio Presents Breakthrough Liquid Biopsy Technology for Extracellular Vesicles in Cell Press - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240603591356\\\/en\\\/2146370\\\/22\\\/Mursla_Bio_Logo.jpg\",\"datePublished\":\"2024-06-03T08:05:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240603591356\\\/en\\\/2146370\\\/22\\\/Mursla_Bio_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240603591356\\\/en\\\/2146370\\\/22\\\/Mursla_Bio_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mursla Bio Presents Breakthrough Liquid Biopsy Technology for Extracellular Vesicles in Cell Press\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mursla Bio Presents Breakthrough Liquid Biopsy Technology for Extracellular Vesicles in Cell Press - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/","og_locale":"en_US","og_type":"article","og_title":"Mursla Bio Presents Breakthrough Liquid Biopsy Technology for Extracellular Vesicles in Cell Press - Pharma Trend","og_description":"Novel and scalable analysis of extracellular vesicles sub-types detailed in Cell Press\u2019 iScience CAMBRIDGE, England–(BUSINESS WIRE)–#Cambridge—Mursla Bio is pleased to announce the publication of its latest peer-reviewed paper in iScience, an interdisciplinary journal of the esteemed Cell Press. The paper showcases Mursla Bio\u2019s breakthrough technology for the analysis of extracellular vesicles (EV) sub-types within biofluids ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/","og_site_name":"Pharma Trend","article_published_time":"2024-06-03T08:05:05+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240603591356\/en\/2146370\/22\/Mursla_Bio_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Mursla Bio Presents Breakthrough Liquid Biopsy Technology for Extracellular Vesicles in Cell Press","datePublished":"2024-06-03T08:05:05+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/"},"wordCount":295,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240603591356\/en\/2146370\/22\/Mursla_Bio_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/","url":"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/","name":"Mursla Bio Presents Breakthrough Liquid Biopsy Technology for Extracellular Vesicles in Cell Press - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240603591356\/en\/2146370\/22\/Mursla_Bio_Logo.jpg","datePublished":"2024-06-03T08:05:05+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240603591356\/en\/2146370\/22\/Mursla_Bio_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240603591356\/en\/2146370\/22\/Mursla_Bio_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/mursla-bio-presents-breakthrough-liquid-biopsy-technology-for-extracellular-vesicles-in-cell-press\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Mursla Bio Presents Breakthrough Liquid Biopsy Technology for Extracellular Vesicles in Cell Press"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59472"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59472\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}